DOLIPRANE
1 G · comprime secable · box 10 tablets
PARACETAMOLReference dated : 2026-10-01. Confirm price and availability with a pharmacist.
Public price
13,10 MAD
Laboratory
BOTTU
Composition and presentation
DOLIPRANE — PARACETAMOL. Listed presentation: 1 G · COMPRIME SECABLE · 1 BOITE 10 COMPRIME.
Full clinical reference
Additional sections are available in French. Read the original document; the information concerns the French reference product.
Uses
Symptomatic treatment of mild to moderate pain and/or fever.
Adults and children from 50 kg (approximately 15 years).
Pregnancy and breastfeeding
Pregnancy
A vast amount of data concerning pregnant women demonstrates the absence of any malformation or any fetal/neonatal toxicity. Epidemiological studies dedicated to the neurodevelopment of children exposed to paracetamol in utero produce inconclusive results. If this proves necessary from a clinical point of view, paracetamol can be used during pregnancy; however, it should be used at the lowest effective dose, for the shortest possible duration and at the lowest possible frequency.
Breastfeeding
After administration, paracetamol is eliminated in small amounts in breast milk. At therapeutic doses, the administration of this medicine is possible during breastfeeding.
Fertility
Due to the potential mechanism of action on cyclo-oxygenases and prostaglandin synthesis, paracetamol could alter fertility in women, through an effect on ovulation reversible upon discontinuation of treatment.
Effects on male fertility have been observed in an animal study. The relevance of these effects in humans is unknown.
Driving
Paracetamol has no effect or only a negligible effect on the ability to drive vehicles and use machines.
Adverse effects
Adverse effects are classified by system-organ class. Their frequencies are defined as follows:
· Very common ( ≥ 1/10)
· Common ( ≥ 1/100 to < 1/10)
· Uncommon ( ≥ 1/1 000 to < 1/100)
· Rare ( ≥ 1/10 000 to < 1/1 000)
· Very rare (< 1/10 000)
· Frequency unknown (cannot be estimated based on available data)
| System organ class | Rare ( ≥ 1/10 000 to < 1/1 000) | Very rare (< 1/10 000) | Frequency unknown |
| Hematological and lymphatic system disorders | Thrombocytopenia, Leucopenia, Neutropenia | ||
| Immune system disorders | Hypersensitivity reactions 1 | Anaphylactic reaction (including hypotension) 1, Anaphylactic shock 1, Angioedema (Quincke's edema) 1 | |
| Respiratory, thoracic and mediastinal disorders | Bronchospasm (cases of bronchospasm have been identified with paracetamol, mostly in asthmatic patients sensitive to aspirin or other non-steroidal anti-inflammatory drugs). | ||
| Metabolism and nutrition disorders | Metabolic acidosis with high anion gap 3 | ||
| Gastrointestinal disorders | Diarrhoea, Abdominal pain. | ||
| Hepatobiliary disorders | Increase in liver enzymes | ||
| Skin and subcutaneous tissue disorders | Erythema 1, Urticaria 1, Skin rash 1, Purpura 2 | Serious skin reactions 1 | Fixed pigment erythema |
| 1 Their occurrence requires immediate and permanent discontinuation of this medicinal product and related medicinal products. 2 The occurrence of this effect requires immediate discontinuation of this medicinal product. The medicinal product may be reintroduced only on medical advice. 3 Cases of metabolic acidosis with high anion gap due to pyroglutamic acidosis have been observed in patients presenting risk factors and taking paracetamol (see section 4.4). A pyroglutamic acidosis may occur in these patients due to low glutathione levels | |||
Reporting of suspected adverse effects
Reporting suspected adverse effects after the medicinal product has been authorised is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals report any suspected adverse effect via the national reporting system: French National Agency for Medicines and Health Products Safety (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr/ .
Hospital price
8,20 MAD
Commercial status
Commercialisé
Administration route
oral
Type
Generic
Therapeutic class
ANTALGIQUES-ANALGESIQUES-ANTIPYRETIQUES-ANTI-INFLAMMATOIRES-ANTISPASMODIQUES
Generic group in the pilot directory : PARACETAMOL 1 G COMPRIME SECABLE · Édition Projet – Janvier 2026
References and update dates
AMMPS — catalogue marocain officiel · 2026-10-01
Product and price referenceThis information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-10-01: 13,10 MAD
Reference price recorded since 2017-12-18: 14,00 MAD
Referenced presentations and strengths
DOLIPRANE
300 MG · poudre pour solution buvable · box 12 sachets
12,85 MAD
DOLIPRANE
150 MG · suppository · box 10 suppositoire
9,70 MAD
DOLIPRANE
200 MG · suppository · box 10 suppositoire
11,75 MAD
DOLIPRANE
100 MG · suppository · box 10 suppositoire
8,60 MAD
DOLIPRANE
150 MG · poudre pour solution buvable · box 12 sachets
9,70 MAD
DOLIPRANE
100 MG · poudre pour solution buvable · box 12 sachets
8,60 MAD
DOLIPRANE
200 MG · poudre pour solution buvable · box 12 sachets
11,20 MAD
DOLIPRANE
500 MG · effervescent tablet · box 16 tablets
14,80 MAD
DOLIPRANE
1 G · suppository · box 10 suppositoire
14,40 MAD
DOLIPRANE
1 G · effervescent tablet · box 8 tablets
15,80 MAD
DOLIPRANE
300 MG · suppository · box 10 suppositoire
12,85 MAD
DOLIPRANE
500 MG · capsule · box 16 capsules
14,30 MAD
Same ingredient, strength and form
This grouping does not establish interchangeability.
Other strengths and forms
Routes and instructions may differ.
- ALGO · 500 MG · tablet · box of 20
- AMIPAR · 10 MG / ML · solution for infusion · poche de 100 ml
- ANDOL · 500 MG · tablet · box 20 tablets
- ANDOL · 500 MG · effervescent tablet · box 16 tablets effervescent
- ANDOL · 500 MG · effervescent tablet · box 16 tablets effervescent
- ANDOL · 1 G · effervescent tablet · box 8 tablets effervescent
- ANDOL · 10 MG / ML · solution injectable pour perfusion en flacon · box of 12
- ANDOL · 0,03 · oral solution · bottle de 90 ml
- ANDOL · 10 MG / ML · solution injectable pour perfusion · box of 1 poche de 100 ml
- ANDOL / ML · 10 MG · solution pour perfusion en poche · poche de 100 ml
- ANDOL · 1000 MG · effervescent tablet · box of 8
- ANDOL 3 % · 3 % · oral solution · bottle de 90 ml
